ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,223.95
0.84%
Dow Jones
40,287.53
0.00%
Gold vs US Dollar
2,398.395
-0.10%
Brent Oil
81.405
-1.06%
Bitcoin
67,573.61
-0.86%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Zymeworks BC Inc (ZA8) Share Price

ZA8 Zymeworks BC Inc

9.00
0.00 (0.00%)
12:00:21 - Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Zymeworks BC Inc TG:ZA8 Tradegate (DE) Ordinary Share  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   0.00 0.00 9.00 8.90 9.10 0.00 0.00  0.00 11:00:21   
 Type  Size  Price  Time  Units 
   0.00  
 
Recent News
DateTimeSource
HeadlineMore ZA8 News
22/07/202411:00UKREGZymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
11/07/202411:30UKREGZymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
17/06/202411:00GLOBEZymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
10/06/202411:00GLOBEZymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
28/05/202411:30GLOBEZymeworks Announces Participation in Upcoming Investor Conferences
02/05/202421:05GLOBEZymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
30/04/202411:00GLOBEZymeworks Announces Participation in Upcoming Investor Conferences
Period
Draw mode
Data Downloads for ZA8

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Zymeworks BC Inc Articles